Micaelle Martin
Nurse Practitioner · East Windsor, CTNPI 1154560852
Payments from drug & device makers
Across 122 payments — averaging $20.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$615
- GSK$240
- Pfizer$191
- Abbott$169
- Boehringer Ingelheim$161
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$146
- plus $945 from 15 others
What the payments were for
- Food & beverage$2,469100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 35 | $615 |
| GSK | 9 | $240 |
| Pfizer | 9 | $191 |
| Abbott | 8 | $169 |
| Boehringer Ingelheim | 7 | $161 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $146 |
| AstraZeneca | 7 | $146 |
| Bayer | 6 | $144 |
| Lilly USA, LLC | 6 | $134 |
| Sanofi-aventis U.S. LLC | 6 | $112 |
| Exact Sciences | 4 | $81 |
| Johnson & Johnson | 3 | $63 |
| Ironwood Pharmaceuticals, Inc | 2 | $47 |
| Novartis | 2 | $47 |
| Amarin Pharma, Inc. | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 3 | $37 |
| Corcept Therapeutics | 1 | $25 |
| Antares Pharma, Inc. | 1 | $24 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Merck | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
How this compares
$2,469 in reported general payments places this provider in the 90th percentile of 1,162 nurse practitioner providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 24 | $35,150 |
| Amlodipine Besylate | 19 | $53 |
| Metformin Hcl | 12 | $28 |
| Amlodipine-AtorvastatinAmlodipine/Atorvastatin | 11 | $8 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $615 | $35,15024 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,162 nurse practitioner providers in Connecticut.
Other nurse practitioner in East Windsor
- Lindita VincaCheshire$427K
- Catherine MilnePlymouth$361K
- Michele NovellaDanbury$331K
- Tiffany RydzNewtown$49K
- Paul FidrychNorwich$23K
- Priscilla QuilterNorwich$21K
- Kimberly BoldonMiddletown$19K
- Emma RobinsonStamford$17K
- Janice TavaresBridgeport$17K
- Kelly WilberWaterbury$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.